Seamless
integration of convergent
technologies-
leading
the path to Personalized Healthcare
Multifunctional nanoparticles is a
key strategic advantage for our
company in achieving our main goal
of advancing Personalized
Healthcare, an approach that seeks
to tailor treatments to specific
cancer treatments based on seamless
integration of latest scientific
understanding of disease at the
molecular level and innovative
nanotechnology.
The technological integration of
detection, targeted therapeutics and
clinical monitoring of biomarkers
enables seamless collaboration along
the whole value chain, from early
detection to treatment. This is
particularly important since
personalized healthcare starts early
in the disease management process.
Our completed proof of concept
studies in animal models, using this
approach already shown clear
benefits: